CRT Fellows Virtual Course
Details
Date
- America/New_York
Adhir Shroff
Adhir Shroff is a cardiologist at UIC Medical Centre, Chicago, Illinois, USA.
Read MoreAdhir Shroff is a cardiologist at UIC Medical Centre, Chicago, Illinois, USA.
Show LessAlexander Truesdell
Alexander Truesdell works at Virginia Heart, Falls Church, VA, USA.
Read MoreAlexander Truesdell works at Virginia Heart, Falls Church, VA, USA.
Show LessAllen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read MoreAllen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show LessAloke Finn
Works at CVPath Institute, Inc., Gaithersburg, MD, USA. Features in 2 videos on Wondr Medical....
Read MoreWorks at CVPath Institute, Inc., Gaithersburg, MD, USA. Features in 2 videos on Wondr Medical. Aloke Finn generally speaks on Drug coated balloons (DCB), Primary Percutaneous Coronary Intervention (PPCI), Stents, Drug Eluting Stents (DES), and In-stent Restenosis (ISR).
Show LessAntonio Colombo
A consultant cadiologist at San Raffaele Hospital, Milan, Italy. Features in 9 videos on Wondr...
Read MoreA consultant cadiologist at San Raffaele Hospital, Milan, Italy. Features in 9 videos on Wondr Medical. Antonio Colombo generally speaks on Multi Vessel Disease, Intervention, Interventional Cardiology Review, Rotational Atherectomy, and Stable Coronary Artery Disease (CAD).
Show LessAravinda Nanjundappa
Works at Charleston Division School of Medicine, Charleston, WV, USA. Features in 1 video on...
Read MoreWorks at Charleston Division School of Medicine, Charleston, WV, USA. Features in 1 video on Wondr Medical. Aravinda Nanjundappa generally speaks on Aorta and Endovascular.
Show LessArthur Lee
Works at The Cardiac and Vascular Institute, Gainesville, FL, USA. Features in 1 video on Wondr...
Read MoreWorks at The Cardiac and Vascular Institute, Gainesville, FL, USA. Features in 1 video on Wondr Medical. Arthur Lee generally speaks on Drug Eluting Stents (DES), Drug Coated Balloon (DCB), and Chronic Limb Ischaemia (CLI, coronary access).
Show LessBruce Samuels
Dr. Bruce Samuels is an interventional cardiologist on staff at Cedars-Sinai Medical Center...
Read MoreDr. Bruce Samuels is an interventional cardiologist on staff at Cedars-Sinai Medical Center (CSMC) in Los Angeles, California. Dr. Samuels completed his medical studies at Albert Einstein College of Medicine in New York before returning to Southern California to complete his residency and chief residency in Internal Medicine at Harbor-UCLA Medical Center. At CSMC, he trained in both general and interventional cardiology before joining the medical staff there. In addition to his clinical practice in coronary intervention, Dr. Samuels has actively participated in numerous interventional trials including IVUS guided therapy, coronary physiology and microvascular disease. He is also working closely with the Barbra Streisand Women’s Heart Center based at CSMC, working as an interventionalist in the active coronary reactivity research there. As co-chair of a 30-day readmissions task force, he has helped to shape policy for CSMC in its efforts to improve quality delivery of care. He has frequently been invited as faculty to many scientific meetings and is a sought after speaker for numerous peer educational platforms. Dr. Samuels is a fellow of the American College of Cardiology and is Board Certified in Internal Medicine, Cardiovascular Diseases, and Interventional Cardiology. He is married with three sons; his outside interests include contemporary art and long distance running.
Show LessCharan Yerasi
Charan Yerasi is an interventional cardiology fellow at MedStar Washington Hospital Center,...
Read MoreCharan Yerasi is an interventional cardiology fellow at MedStar Washington Hospital Center, Washington, DC, USA.
Show LessChirag Bavishi
Chirag Bavishi is a cardiologist at Rhode Island Hospital, Rhode Island, US.
Read MoreChirag Bavishi is a cardiologist at Rhode Island Hospital, Rhode Island, US.
Show LessDavid Kandzari
Dr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service...
Read MoreDr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology of the Piedmont Heart Institute; and Chief Scientific Officer for Piedmont Healthcare in Atlanta, Georgia. Dr. Kandzari specializes in cardiovascular disease, peripheral arterial disease and interventional cardiology. A graduate of Duke University School of Medicine, he completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. Dr. Kandzari is the former Director of Interventional Cardiology Research at the Scripps Clinic in La Jolla, California. Before joining the Scripps faculty, he also served as Chief Medical Officer for the Cordis Corporation, a Johnson & Johnson Company. He has also served as a Medical Officer for the Center for Devices and Radiological Health for the United States Food and Drug Administration. Board certified by the American Board of Internal Medicine and its subspecialty Board of Cardiovascular Disease and Board of Interventional Cardiology, Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 400 studies, book chapters and scientific reviews, and has delivered more than 700 lectures, both nationally and internationally, on a variety of issues related to both interventional and general cardiology. Dr. Kandzari has been consecutively voted as one of Atlanta's Top Doctors by Atlanta Magazine from 2011 to 2021, and is peer-nominated in the top 1% of cardiologists by U.S News and World Report.
Show LessDominick Angiolillo
Works at University of Florida College of Medicine - Jacksonville, Jacksonville, FL, USA....
Read MoreWorks at University of Florida College of Medicine - Jacksonville, Jacksonville, FL, USA. Features in 2 videos on Wondr Medical. Dominick Angiolillo generally speaks on Coronary Interventions, Anti-Platelet Drugs , Stable Coronary Artery Disease (CAD), Acute Coronary Syndromes (ACS), and Primary Percutaneous Coronary Intervention (PPCI).
Show LessDr. William Fearon
Dr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia...
Read MoreDr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society. He completed an Internal Medicine residency at Stanford University Medical Center serving an extra year as a Medical Chief Resident. He completed a General Cardiology and Interventional Cardiology fellowship at Stanford, spending his third year as the Chief Cardiology Fellow. He is currently a Professor of Cardiology and Director of Interventional Cardiology at Stanford University School of Mediciner. Dr. Fearon is board certified in cardiovascular medicine and interventional cardiology, and he is a fellow of the American College of Cardiology, the American Heart Association, and the Society of Cardiovascular Angiography and Interventions. He has been elected to the American Society for Clinical Investigation. Dr. Fearon’s primary area of research interest is in coronary physiology. He was the US principal investigator and senior author of the FAME trial, published in the New England Journal of Medicine and was a co-principal investigator and senior author of the FAME 2 trial, also published in the New England Journal of Medicine. He is now the principal investigator of the international FAME 3 trial comparing bypass surgery to fractional flow reserve guided percutaneous coronary intervention. He serves on the editorial board of the Journal of the American College of Cardiology, Circulation, JACC Cardiovascular Interventions, and Circulation: Cardiovascular Interventions. He was the principal investigator on an R01 and is the PI on an R61/R33 NIH award evaluating cardiac allograft vasculopathy early after transplantation. Dr. Fearon’s clinical activities include not only percutaneous coronary intervention, but also transcatheter aortic valve replacement. He was a coauthor on the PARTNER 2A Trial published in the New England Journal of Medicine.
Show LessDragos Alexandru
Dragos Alexandru is a clinical specialist at Asahi Intecc, US.
Read MoreDragos Alexandru is a clinical specialist at Asahi Intecc, US.
Show LessDuane Pinto
Dr. Pinto received his B.A., cum Laude, from Dartmouth College in Hanover, NH and M.D. degree...
Read MoreDr. Pinto received his B.A., cum Laude, from Dartmouth College in Hanover, NH and M.D. degree from the Georgetown University, cum Laude and Alpha Omega Alpha. He was an Intern, Resident, Chief Resident, General Cardiology Fellow and Interventional Cardiology Fellow at Harvard Medical School and Beth Israel Hospital, Boston, MA. Dr. Pinto is an Associate Professor of Medicine at Harvard Medical School and serves as the Director of the Cardiac Intensive Care Unit, Associate Chief of the Interventional Section and Director of the General Cardiology Fellowship Program at Beth Israel Deaconess Medical Center. He has been awarded cardiology fellow teaching and mentorship awards from Harvard Medical School. His clinical expertise is in general and interventional cardiology. In addition to a busy outpatient practice, he performs coronary and peripheral angioplasty and stenting procedures. These include stenting and other procedures in the heart, leg, abdominal and neck arteries. Dr. Pinto has research interests in a wide variety of topics including acute myocardial infarction studies, unstable angina studies, interventional trials, peripheral interventional trials specializing in clinical outcome, comparative effectiveness and cost-effectiveness studies. Dr. Pinto is the editor of the Controversies in Cardiology section for Circulation. He is a manuscript reviewer for the New England Journal, Circulation and the Journal of the American College of Cardiology. He has published over 75 articles in journals such as The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology and JAMA. His work highlights the management and outcomes of patients with cardiac and vascular disorders.
Show LessEberhard Grube
Prof. Grube is Professor of Medicine, Head, Center of Innovative Interventions in Cardiology...
Read MoreProf. Grube is Professor of Medicine, Head, Center of Innovative Interventions in Cardiology (CIIC) University Hospital Bonn, Germany and Consulting Professor, Division of Cardiovascular Medicine, at Stanford University School of Medicine. He received his first degree in Medicine at the Rheinische Friedrich-Wilhelm-University in Bonn. His cardiology training was completed at University of Wisconsin, Medical School and University of Bonn, Medical School. He received his Board Certification in Internal Medicine, in Cardiology and in Angiology from the North Rhine Chamber of Medical Doctors and his post-doctoral lecturing qualification “Internal Medicine“ from the Rheinische Friedrich-Wilhelm-University in Bonn. He is a fellow of the American College of Cardiology, the American College of Angiology and the Society for Cardiac Angiography & Interventions. His research interest includes drug eluting stents, distal protection devices, debulking devices, restenosis and in-stent restenosis.
Show LessEmmanouil Brilakis
Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI is Director of the Center for Complex...
Read MoreEmmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI is Director of the Center for Complex Coronary Interventions at the Minneapolis Heart Institute and Chairman of the Center for Coronary Artery Disease at the Minneapolis Heart Institute Foundation. After graduating from Lycee Leonin de Patissia, Dr. Brilakis received his medical degree from the National Kapodistrian University of Athens, Greece. He trained in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology at the Mayo Clinic. He also completed a Masters in Clinical Research at the Mayo Clinic and a PhD in Clinical Research at the National Kapodistrian University of Athens, Greece. He served as director of the cardiac catheterization laboratories at VA North Texas Health Care System from 2004-2016. He was on the faculty of the University of Texas Southwestern Medical School from 2004-2018. Dr. Brilakis leads a large clinical trial group investigating treatment of chronic total occlusions, prevention and treatment of saphenous vein graft disease, prevention and management of complications, intracoronary imaging, antiplatelet treatment optimization post coronary stenting, radiation safety in the catheterization laboratory, and implementation of novel technologies in healthcare. Dr. Brilakis has authored or co-authored over 600 manuscripts and has written the Manual of CTO Interventions, now in its second edition. He directs the Complex Coronary Interventions Webcast series and is on the Board of the Cardiovascular Innovations Foundation. He is an associate editor for Circulation and an editorial board member and reviewer for several journals and grant agencies. He is lecturing and proctoring at several institutions in the United States and abroad.
Show LessEvan Shlofmitz
Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at...
Read MoreDr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at St. Francis Hospital - The Heart Center in Roslyn, NY. He completed a fellowship in Interventional Cardiology at Georgetown University/MedStar Washington Hospital Center. He previously completed an Intravascular Imaging and Physiology fellowship at the Cardiovascular Research Foundation (CRF) and Columbia University Medical Center (CUMC), a Cardiovascular Disease fellowship at Northwell Health and served as Chief Resident for Internal Medicine at New York Presbyterian Queens. He serves on SCAI's IHD Council and is a co-director of Optimizing PCI (OPCI). His research interests have centered on intravascular imaging, the treatment of calcified coronary artery disease, in-stent restenosis and the optimization of stent implantation, with more than 100 publications in peer-reviewed journals.
Show LessFarouc Jaffer
Dr. Farouc Jaffer graduated from Stanford University in 1990 with a B.S. in Mathematical and...
Read MoreDr. Farouc Jaffer graduated from Stanford University in 1990 with a B.S. in Mathematical and Computational Sciences, and received in MD and PhD in Biophysics from the University of Pennsylvania of Medicine in 1996. He completed a residency in internal medicine at the Brigham and Women's Hospital, followed by a fellowship in cardiovascular medicine and interventional cardiology at Massachusetts General Hospital. In 2003, he joined the Cardiology Division as faculty. Dr. Jaffer is currently an Associate Professor of Medicine at Harvard Medical School and an Attending Interventional Cardiologist at Massachusetts General Hospital. He is Director of Coronary Intervention and Director of the Chronic Total Occlusion (CTO) PCI Program at at Massachusetts General Hospital. The MGH is a leading center for treating the most complex coronary blockages, such as CTO. Many patients, previously without options, have successfully underwent CTO PCI, and have experienced marked reductions in angina (chest pain) and shortness of breath. Dr. Jaffer is also a Principal Investigator in the MGH Cardiovascular Research Center where his NIH-funded laboratory develops novel molecular imaging approaches to image high-risk plaques and blood clots, to better prevent heart attacks, strokes, and venous blood clots.
Show LessGary Mintz
Gary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF,...
Read MoreGary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF, New York, NY) and a Director of Transcatheter Cardiovascular Therapeutics (TCT). He is the author of more than 1000 peer reviewed articles, 60 book chapters, 4 books, and 850 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and (especially) intravascular imaging and physiology. In 2005, Dr. Mintz published his single-authored textbook Intracoronary Ultrasound that has now been translated into Chinese. In 2014, Dr. Mintz received the Master of the Masters Career Achievement Award at the TCTAP-Cardiovascular Summit in Seoul, Korea; in 2015 Dr. Mintz received the Chien Foundation Outstanding Lectureship & Lifetime Achievement Award, also presented at TCTAP-Cardiovascular Summit in Seoul, Korea; in 2017 Dr. Mintz received the Outstanding Achievement Award at CBS 2017, Nanjing, China; in 2018 Dr. Mintz received the Career Achievement Award at NFIC in Krakow, Poland; and in 2020 Dr. Mintz received the Jiangsu Friendship Award from the People’s Government of Jiangsu Province, China, the highest award presented to a non-Chinese. He also serves as a Senior Scientist and Advisor at the Medstar Cardiovascular Research Network, Washington, DC. Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University (now part of Drexel University), in 1974, both in Philadelphia, PA. He finished his internship in 1975, residency in 1976, and cardiology fellowship in 1978, each at Hahnemann University. He joined the Hahnemann University Department of Medicine faculty in 1978 and was ultimately promoted to Professor of Medicine in 1987 before joining CRF in 1991. His past appointments at CRF have included Chief Medical Officer and Editor-in-Chief (and one of the founders) of TCTMD.com.
Show LessGoran Stankovic
Prof Goran Stankovic is a Professor of Internal Medicine and Cardiology at the Faculty of...
Read MoreProf Goran Stankovic is a Professor of Internal Medicine and Cardiology at the Faculty of Medicine, University of Belgrade, Head of the Department of Cardiology, Clinical Center of Serbia and Chief of Invasive Diagnostics and Interventional Cardiology. Prof. Stankovic was awarded Fellow of the European Society of Cardiology (FESC) in 2003, and Fellow of the American College of Cardiology (FACC) in 2005. He has been a member of European Association for Percutaneous Coronary Interventions (EAPCI) since 2007 and is currently a member of the EAPCI Nominating Committee. He has been one of the founding members and is currently the president of the European Bifurcation Club, and a member of the Asian and Indian Bifurcation Clubs. Professor Stankovic serves on the editorial boards of Journal of the American College of Cardiology, Eurointervention, European Journal of Cardiovascular Medicine, Advances in Interventional Cardiology Journal, and Heart and Blood Vessels – Journal of Cardiology Society of Serbia. For the consecutive years 2005-2014 Professor Stankovic was awarded Elite Reviewer for Journal of American college of Cardiology. In 2009 he received Simon Dack Award for outstanding Scholarship from the American College of Cardiology Foundation.
Show LessHabib Samady
Dr Habib Samady is an interventional cardiologist and serves as President of the Georgia Heart...
Read MoreDr Habib Samady is an interventional cardiologist and serves as President of the Georgia Heart Institute, the heart and vascular program of Northeast Georgia Health System. He is also Director of the Georgia Center for Cardiovascular Biomechanics and Modeling and Adjunct Professor of Medicine at Emory University. Dr Samady is recognized as one of the foremost international experts in coronary physiology. He earned his medical degree from the University of Sheffield in England, and completed his residency training in both London and in Sheffield. He subsequently completed an internal medicine residency and chief residency at the University of Connecticut, before his fellowship in general cardiology, nuclear cardiology, and interventional cardiology at Yale University in Connecticut.
Show LessHashim Hayder
Hashim Hayder is an interventional cardiologist at MedStar Washington Hospital Center,...
Read MoreHashim Hayder is an interventional cardiologist at MedStar Washington Hospital Center, Washington, DC, USA.
Show LessHorst Sievert
A consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 63 videos on...
Read MoreA consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 63 videos on Wondr Medical. Horst Sievert generally speaks on Atrial Fibrillation, Left Atrial Appendage (Closure), Live Cases, Transcatheter Aortic Valve Implantation (TAVR / TAVI), and Left Main Stem (LMS).
Show LessItsik Ben-Dor
Works at MedStar Washington Hospital Center, Washington, District of Columbia, USA. Features in 4...
Read MoreWorks at MedStar Washington Hospital Center, Washington, District of Columbia, USA. Features in 4 videos on Wondr Medical. Itsik Ben-Dor generally speaks on Coronary Interventions, Atherectomy, Transcatheter Aortic Valve Implantation (TAVR / TAVI), and General.
Show LessJason Foerst
Dr. Jason Foerst is an Associate Professor in Cardiology at Virginia Tech-Carilion School of...
Read MoreDr. Jason Foerst is an Associate Professor in Cardiology at Virginia Tech-Carilion School of Medicine and Carilion Clinic in Roanoke, VA. He is a structural interventionalist with 12 years of experience in the field. He is actively participating in clinical trials for aortic stenosis, mitral regurgitation, paravalve leak repair, left atrial appendage closure and left ventricular remodeling
Show LessJason Wollmuth
Jason Wollmuth is an interventional cardiologist at Providence Heart and Vascular Institute,...
Read MoreJason Wollmuth is an interventional cardiologist at Providence Heart and Vascular Institute, Portland, Oregon, US.
Show LessJasvindar Singh
Dr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization...
Read MoreDr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization Laboratory at Barnes-Jewish Hospital and Director of Interventional Cardiology. He specializes in coronary and peripheral vascular interventional procedures and spends most of his time in the cardiac catheterization laboratory. His expertise is in complex coronary intervention and also the endovascular treatment of renovascular hypertension, and peripheral arterial occlusive diseases. In addition, he has been involved in research ranging from new coronary devices to intravascular ultrasound and pressure/flow assessment of coronary vessels. He is the Principal Investigator in several high profile multicenter trials evaluating the above. He is actively involved in resident/fellow education and rotate in the coronary care unit twice a year. He has two interventional fellows per year who work closely with him during their training, he also serves as their attending in ½ day in patient clinic. He has second and third year cardiology fellows involved in clinical research protocols in the cath lab and their work has produced three instrumental abstracts/papers which in the first 12 months were presented at major cardiovascular society meetings. Dr. Singh is also the Chairman of ARCH, one of the largest Midwest Interventional Symposium.
Show LessJeffrey Moses
An internationally recognized interventional cardiologist, Dr. Moses has performed more than...
Read MoreAn internationally recognized interventional cardiologist, Dr. Moses has performed more than 15,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the majority of interventional procedures in the U.S. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures.
Show LessJustin Davies
Dr Justin Davies is a honorary interventional cardiologist at Hammersmith Hospital, Imperial...
Read MoreDr Justin Davies is a honorary interventional cardiologist at Hammersmith Hospital, Imperial College NHS Trust, London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents, he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies).
Show LessKevin Croce
Dr. Kevin J. Croce is an interventional cardiologist and the director of the Chronic Total...
Read MoreDr. Kevin J. Croce is an interventional cardiologist and the director of the Chronic Total Occlusion Complex Percutaneous Coronary Intervention Program at Brigham and Women’s Hospital (BWH). He is an assistant professor of medicine at Harvard Medical School (HMS) who also directs the BWH Translational Discovery Laboratory which is a centralized research facility that uses state-of-the-art technology to perform preclinical testing of promising therapies and medical devices. Dr. Croce received his medical and Ph.D. degrees from Tufts University School of Medicine. He completed an internal medicine residency, a cardiology fellowship and an interventional cardiology fellowship at BWH. Dr. Croce is board certified in internal medicine, cardiovascular disease and interventional cardiology. His clinical interests include advanced treatments for obstructive coronary artery disease (CAD), and optimization of antithrombotic and antiplatelet pharmacotherapy. The author of over 50 peer-reviewed publications, Dr. Croce’s research focuses on understanding the molecular pathobiology of atherothrombotic (CAD) and on identifying new targets for CAD treatment. His research has received support from the National Institutes of Health.
Show LessMarvin Eng
Marvin Eng works at Henry Ford Hospital, Detroit, MI, USA.
Read MoreMarvin Eng works at Henry Ford Hospital, Detroit, MI, USA.
Show LessMatheen Khuddus
Matheen Khuddus is a director of cardiovascular research at The Cardiac and Vascular Institute,...
Read MoreMatheen Khuddus is a director of cardiovascular research at The Cardiac and Vascular Institute, Gainesville, Florida, US.
Show LessMichael Cowley
Michael Cowley works at Virginia Commonwealth University Medical Center, Pauley Heart Center,...
Read MoreMichael Cowley works at Virginia Commonwealth University Medical Center, Pauley Heart Center, Richmond, VA, USA.
Show LessMichael Miller
An interventional cardiology at University Hospital - Charlotte, Charlotte, NC, USA. Features in...
Read MoreAn interventional cardiology at University Hospital - Charlotte, Charlotte, NC, USA. Features in 1 video on Wondr Medical. Michael Miller generally speaks on Healthcare and Endovascular.
Show LessMichael Stoner
Michael Stoner works at University of Rochester, Rochester, New York, NY, USA.
Read MoreMichael Stoner works at University of Rochester, Rochester, New York, NY, USA.
Show LessMitul Patel
Works at UCSD Sulpizio Cardiovascular Center and VA San Diego, La Jolla, CA, USA. Features in 1...
Read MoreWorks at UCSD Sulpizio Cardiovascular Center and VA San Diego, La Jolla, CA, USA. Features in 1 video on Wondr Medical. Mitul Patel generally speaks on Chronic Total Occlusion (CTO), Drug Coated Balloon (DCB), and Endovascular.
Show LessMorton Kern
Dr. Kern is Chief of Medicine, VA Long Beach Health Care System, Professor of Medicine,...
Read MoreDr. Kern is Chief of Medicine, VA Long Beach Health Care System, Professor of Medicine, University California, Irvine. He continues to perform and teach cardiac catheterization and PCI. Dr. Kern is ABIM Certified in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology and is a past president and now a Master Fellow of the SCAI. His research interests in coronary blood flow, intravascular physiology, intravascular ultrasound, vulnerable plaque and evaluation of cardiovascular hemodynamics. He has authored several textbooks, notably The Cardiac Catheterization Handbook, 6th ed. and its companion The Interventional Cardiac Cath Handbook, 4th ed.
Show LessNelson Bernardo
An interventional cardiology at MedStar Washington Hospital Center, Washington, District of...
Read MoreAn interventional cardiology at MedStar Washington Hospital Center, Washington, District of Columbia, USA. Features in 2 videos on Wondr Medical. Nelson Bernardo generally speaks on Arterial, Chronic Total Occlusion (CTO), Drug Coated Balloon (DCB), and Imaging.
Show LessNicolas Van Mieghem
Nicolas Van Mieghem is the Clinical Director of Interventional Cardiology and Professor of...
Read MoreNicolas Van Mieghem is the Clinical Director of Interventional Cardiology and Professor of Interventional Cardiology at the Thoraxcenter, Erasmus University Medical Center, Rotterdam. He obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent Fellowships in interventional cardiology in at Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, United States and Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands, he joined the senior staff of the department of interventional cardiology in the Thoraxcenter in February 2010. Professor Van Mieghem’s academic interest is in complex (calcified) coronary lesions, mechanical circulatory support and structural heart interventions. He obtained a PhD based upon his research in transcatheter valve therapies. Professor Van Mieghem is involved in the percutaneous coronary interventions and structural heart program. Professor Van Mieghem has published and co-authored over 400 scientific papers in peer-reviewed journals. He is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and the American College of Cardiology.
Show LessPeter Monteleone
Peter Monteleone is an assistant professor of cardiology at Dell Medical School, University of...
Read MorePeter Monteleone is an assistant professor of cardiology at Dell Medical School, University of Texas at Austin, Texas, US.
Show LessPeter Soukas
Features in 7 videos on Wondr Medical. Peter Soukas generally speaks on Coronary Optical...
Read MoreFeatures in 7 videos on Wondr Medical. Peter Soukas generally speaks on Coronary Optical Coherence Tomography (OCT), Atherectomy, Peripheral Vascular Disease (PVD), Coronary Interventions, and Impella.
Show LessRaj Tayal
Works at John F. Kennedy Medical Center/Newark Beth Israel Medical Center, Warren, NJ, USA....
Read MoreWorks at John F. Kennedy Medical Center/Newark Beth Israel Medical Center, Warren, NJ, USA. Features in 1 video on Wondr Medical. Raj Tayal generally speaks on Impella, Shockwave Lithotripsy (Coronary), Calcified Iliac Disease, and Alternative Access.
Show LessRichard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read MoreDr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show LessRobert Gallino
Robert Gallino is an interventional cardiology at Cardiology Associates, LLC, Olney, Maryland, USA.
Read MoreRobert Gallino is an interventional cardiology at Cardiology Associates, LLC, Olney, Maryland, USA.
Show LessRon Waksman
Ron Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital...
Read MoreRon Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital Center (MWHC) and Director of Cardiovascular Research and Advanced Education for the MedStar Heart and Vascular Institute at the MedStar Washington Hospital Center. With nearly 20 years of experience in leading edge medical technologies, Dr. Waksman is a world-renowned interventional cardiologist and is a highly sought after Principal Investigator for pre-clinical and clinical studies conducted in the United States and abroad. Dr Waksman has performed over 5000 coronary interventions throughout his career.
Show LessRoxana Mehran
A consultant cardiologist at Mount Sinai Hospital, New York, USA. Features in 13 videos on Wondr...
Read MoreA consultant cardiologist at Mount Sinai Hospital, New York, USA. Features in 13 videos on Wondr Medical. Roxana Mehran generally speaks on Anti-Platelet Drugs , Coronary Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS), Cardiovascular Pharmacotherapy, and Cardiac Valves.
Show LessSalman Arain
Works at University of Texas Health Sciences Center - Houston, Houston, TX, USA. Features in 1...
Read MoreWorks at University of Texas Health Sciences Center - Houston, Houston, TX, USA. Features in 1 video on Wondr Medical. Salman Arain generally speaks on Acute Coronary Syndromes (ACS), Primary Percutaneous Coronary Intervention (PPCI), Left Main Stem (LMS), Ventricular Fibrillation (VF), and Extracorporeal membrane oxygenation (ECMO).
Show LessSamin Sharma
Samin Sharma is a consultant cardiologist at Mount Sinai Hospital, New York, USA.
Read MoreSamin Sharma is a consultant cardiologist at Mount Sinai Hospital, New York, USA.
Show LessSamir Pancholy
Works at The Commonwealth Medical College, Scranton, Clarks Summit, PA, USA. Features in 1 video...
Read MoreWorks at The Commonwealth Medical College, Scranton, Clarks Summit, PA, USA. Features in 1 video on Wondr Medical. Samir Pancholy generally speaks on Radial and Acute Coronary Syndromes (ACS).
Show LessShawn Sarin
Works at The George Washington University Medical Centre, Washington, DC, USA. Features in 1...
Read MoreWorks at The George Washington University Medical Centre, Washington, DC, USA. Features in 1 video on Wondr Medical. Shawn Sarin generally speaks on Endovascular.
Show LessSimon Walsh
Dr Simon Walsh has been working as a Consultant Cardiologist at the Belfast Trust for over 10...
Read MoreDr Simon Walsh has been working as a Consultant Cardiologist at the Belfast Trust for over 10 years. It is one of the largest NHS trusts in the UK. The centre performs ~2750 PCI per year, with 650-700 STEMI and calcium modification in ~10% of our PCI cases. Dr Walsh also works internationally as an educator, teaching advanced techniques for complex PCI and CTO PCI. This involves training visiting Cardiologists in Belfast retrograde CTO techniques, antegrade dissection and re-entry CTO techniques and other advanced PCI procedures. He has visited multiple centres in the UK, Ireland, Europe, Australia, Asia and North America to act as a visiting proctor for complex PCI and CTO PCI cases. Dr Walsh’s research interests include PCI, coronary artery disease, defibrillation, acute coronary syndromes and chronic total occlusions. Research responsibilities have included acting as a recruiting investigator for the >25 multicentre studies over the last 17 years. He acted as a primary investigator for numerous international trials including the Evolve, Noble, Leaders Free and Ischemia multicentre studies. He has been the lead UK investigator for the October trial, Syntax 2, Recharge and Ischaemia-CTO. He is also the Chief Investigator for the Consistent CTO, Celtic Bifurcation and Discrete CTO trials.
Show LessSripal Bangalore
Dr. Bangalore is an interventional cardiologist and a Professor of Medicine at New York...
Read MoreDr. Bangalore is an interventional cardiologist and a Professor of Medicine at New York University School of Medicine. He is the Director of Complex Coronary Intervention; Director of Research for the cardiac catheterization laboratory and the Director for the Cardiovascular Outcomes Group. His clinical expertise is in complex coronary intervention including CTOs, ultra low volume/zero contrast PCI, and renal denervation. His research interests are in comparative effectiveness studies for cardiovascular diseases, particularly stable ischemic heart disease, acute coronary syndromes, hypertension and dyslipidemia. Dr. Bangalore has received grants from the National Institutes of Health, Agency for Healthcare Research and Quality, American Heart Association and from the industry. He has published over 350 articles in leading national and international journals including the NEJM, JAMA, Lancet, Circulation and JACC. He is the principal investigator of the ISCHEMIA CKD trial, which is a randomized trial in patients with advanced chronic kidney disease and abnormal stress test, carried out in 33 countries and up to 350 clinical sites. The trial is testing the effectiveness of an initial invasive strategy of cath and revascularization with optimal medical therapy versus a conservative strategy of optimal medical therapy alone in patients with chronic kidney disease. His other areas of interest include comparative effectiveness of coronary artery bypass surgery (CABG) vs. percutaneous coronary intervention (PCI), evaluating the efficacy and safety of various stent types in patients undergoing PCI, including patients with diabetes and those in patients with ST segment elevation myocardial infarction and comparative effectiveness of drug eluting stents vs. bare metal stents. He has won a number of awards including the Dr. Gregory Braden Memorial Interventional Cardiology Fellow of the Year Award from the Society for Cardiovascular Angiography and Intervention and the Douglas P. Zipes Distinguished Young Scientist award from the American College of Cardiology.
Show LessTej Sheth
Dr. Sheth is an Associate Professor in the Department of Medicine at McMaster University. He is a...
Read MoreDr. Sheth is an Associate Professor in the Department of Medicine at McMaster University. He is a Principal Investigator for Acute Coronary Syndrome/Interventional Cardiology Program at the Population Health Research Institute. His research interest is in invasive and non-invasive coronary imaging modalities. He has served as chair of national meetings focusing on coronary optical coherence tomography imaging and is the Director of McMaster University’s Fundamentals of Coronary Optical Coherence Tomography Training Course.
Show LessVenkatesh Ramaiah
A vascular surgeon at Arizona Heart Institute, Phoenix, AZ, USA. Features in 6 videos on Wondr...
Read MoreA vascular surgeon at Arizona Heart Institute, Phoenix, AZ, USA. Features in 6 videos on Wondr Medical. Venkatesh Ramaiah generally speaks on Abdominal Aortic Aneurysm (AAA), Live Cases, Chronic Total Occlusion (CTO), Drug Coated Balloon (DCB), and Orbital Atherectomy .
Show LessWalter Tan
Works at Wake Forest Univ - Baptist Hospitals, Winston Salem, NC, USA. Features in 1 video on...
Read MoreWorks at Wake Forest Univ - Baptist Hospitals, Winston Salem, NC, USA. Features in 1 video on Wondr Medical. Walter Tan generally speaks on Chronic Limb Ischaemia (CLI, coronary access) and Endovascular.
Show Less